Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Neuroblastoma 3Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Neoplasm Metastasis 1Motor Activity 1Melanoma 1Lymphoproliferative Disorders 1Lymphoma 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Dendritic Cell Sarcoma, Interdigitating 1Carcinoma, Non-Small-Cell Lung 1Burkitt Lymphoma 1

Interventions

Carboplatin 782Pemetrexed 606Cisplatin 544Paclitaxel 490pembrolizumab 462Docetaxel 440Gemcitabine 328Erlotinib Hydrochloride 307Radiotherapy 255Nivolumab 244Bevacizumab 233osimertinib 177Drug Therapy 164durvalumab 157atezolizumab 135Gefitinib 134Radiosurgery 131Vinorelbine 111Cetuximab 97130-nm albumin-bound paclitaxel 94Ipilimumab 86Magnetic Resonance Spectroscopy 83Taxes 79Surgical Procedures, Operative 74Afatinib 68Albumin-Bound Paclitaxel 66Specimen Handling 61Etoposide 61Cyclophosphamide 60tislelizumab 59

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × beta-Glucans × Clear all
NCT00682032 2025-01-10

The Effect of Beta-glucan in Non-Small Cell Lung Cancer

University of Louisville

Phase NA Recruiting
300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡